Phosphodiesterase Type 5 Inhibitors and Selective Estrogen Receptor Modulators Can Prevent But Not Reverse Myofibroblast Transformation in Peyronie's Disease
Marcus M. Ilg, Simon J. Stafford, Marta Mateus, Stephen A. Bustin, Michael J. Carpenter, Asif Muneer, Trinity J. Bivalacqua, David J. Ralph, Selim Cellek
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Phosphodiesterase Type 5 Inhibitors and Selective Estrogen Receptor Modulators Can Prevent But Not Reverse Myofibroblast Transformation in Peyronie's Disease'. Together they form a unique fingerprint.